9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Workshop on Adverse Drug Reaction Reporting, Pharmacovigilance and Its Implementation in Cancer Hospital in Nepal: An Event Report

      discussion

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Adverse drug reactions are crucial events related to drug usage that ought to be reported and the effects of which can be minimized by careful and vigilant use of drugs. Pharmacovigilance refers to the systematic practice of reporting, assessing and preventing such events. Although such practice is vital in any healthcare system, its actual implementation has been found to be very limited in a country like Nepal. With the aim of disseminating information about such events and the role of healthcare professionals in pharmacovigilance, a one-day workshop was organized with international and national speakers on this subject at Nepal Cancer Hospital and Research Center, Lalitpur, Nepal, which also has a regional pharmacovigilance center . The workshop included lectures and hands-on training and had an audience from diverse fields of healthcare such as pharmacy, medical, surgical and radiation oncology, pathology and nursing staff. The feedback from the participants revealed that practical demonstration and hands-on training with extensive topic coverage were the best feature of the workshop, while less interaction during the lectures was a source of dissatisfaction with a recommendation to conduct more events focused on similar topics in the future.

          Related collections

          Most cited references21

          • Record: found
          • Abstract: not found
          • Article: not found

          VigiBase, the WHO Global ICSR Database System: Basic Facts

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial.

            Data on the adverse effects of newly marketed drugs are limited. Voluntary reporting is an important part of postmarketing surveillance but is underused by physicians. To evaluate the effectiveness of educational outreach visits for improving adverse drug reaction (ADR) reporting by physicians. A cluster-randomized controlled trial covering all National Health System physicians in the north of Portugal, with intervention in March 2004 through July 2004, and 13 to 16 months of follow-up. A total of 1388 physicians were assigned in 4 spatial clusters to the intervention group, and 5063 were assigned in 11 clusters to the control group. One-hour educational outreach visits tailored to training needs identified in a previous study. Change in total number of reported ADRs and number of serious, high-causality, unexpected, and new-drug-related ADRs, using generalized linear mixed models adjusted for baseline ADR reporting, age, specialty, and work setting. At baseline, ADR reporting rates (per 1000 physician-years) did not differ significantly between the intervention groups and the control groups in reporting ADRs overall (7.6 vs 11.3), nor did they differ significantly by category: serious, 4.3 vs 6.0; high-causality, 5.4 vs 7.6; unexpected, 1.6 vs 3.5; and new-drug-related ADRs, 3.7 vs 3.8. (P>.05 for all comparisons). The control group had no significant increase in ADR reports during follow-up. The adjusted increase in ADR reporting rates attributable to intervention was 90.19 for total ADRs (95% confidence interval [CI], 54.51-125.87; relative risk [RR], 10.23; 95% CI, 3.81-27.51), 30.16 for serious ADRs (95% CI, 18.84-41.47; RR, 6.32; 95% CI, 2.09-19.16), 64.90 for high-causality ADRs (95% CI, 38.38-91.42; RR, 8.75; 95% CI, 3.05-25.07), 28.04 for unexpected ADRs (95% CI, 16.25-39.83; RR, 30.21; 95% CI, 4.54-200.84), and 42.17 for new-drug-related ADRs (95% CI, 21.58-62.76; RR, 8.05; 95% CI, 2.10 -30.83). The greatest difference occurred during the first 4 months after intervention, but differences remained statistically significant for 12 months. A targeted outreach program may improve high-quality reporting of ADRs among physicians.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              THE RELATIONSHIP BETWEEN COMMUNICATION APPREHENSION AND ACADEMIC ACHIEVEMENT AMONG COLLEGE STUDENTS

                Bookmark

                Author and article information

                Journal
                Adv Med Educ Pract
                Adv Med Educ Pract
                AMEP
                amep
                Advances in Medical Education and Practice
                Dove
                1179-7258
                08 January 2020
                2020
                : 11
                : 9-14
                Affiliations
                [1 ]Department of Pharmacy, Nepal Cancer Hospital and Research Center , Lalitpur, Nepal
                [2 ]Infection Prevention and Control Unit, Nepal Cancer Hospital and Research Center , Lalitpur, Nepal
                [3 ]Department of Pharmacology, Era’s Lucknow Medical College , Lucknow, UP, India
                [4 ]Hematology and Hemato Oncology, PSRI Hospital , New Delhi 110017, India
                [5 ]Department of Medical Oncology, Nepal Cancer Hospital and Research Center , Lalitpur, Nepal
                Author notes
                Correspondence: Sunil Shrestha Department of Pharmacy, Nepal Cancer Hospital and Research Center , Harisiddhi, Lalitpur, NepalTel +977-9851220488 Email sunilcresta@gmail.com
                Author information
                http://orcid.org/0000-0002-9174-7120
                http://orcid.org/0000-0002-0137-1888
                http://orcid.org/0000-0002-3451-0514
                Article
                225208
                10.2147/AMEP.S225208
                6955607
                32021537
                b2fb98e3-6156-4846-b656-da151e48c5c0
                © 2020 Shrestha et al.

                This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php).

                History
                : 30 July 2019
                : 29 November 2019
                Page count
                References: 27, Pages: 6
                Categories
                Perspectives

                adverse drug reaction,adr reporting,nepal,pharmacovigilance,workshop

                Comments

                Comment on this article